The debt payments have stopped and RXMD will be debt free upon uplist. Armen has said "The company’s goal is to repay the debt from the capital raised at the uplist offering."
RXMD has a plan and they are executing it. It is an exciting time to be invested. Upon uplist RXMD will also have the funding to expand their ClearMetrX technology business, which is far more profitable than prescription fulfillment.
Don't forget. When covid testing ends if it ever does. They plan on rolling this effort into allergy, std ect testing. They have talked about this in a PR. Testing won't end but it will change.
News 
Market Data 
Discover 
